Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Stress significantly contributes to hair loss, especially in women and those aged 31-40.

Seborrheic dermatitis is influenced by diet, genetics, and psychological factors.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Hair care products are important for appearance and self-esteem, and choosing the right ones can help maintain healthy hair.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Moth-eaten alopecia is linked to various skin diseases and requires early treatment to prevent worsening.

Different rheumatological diseases can cause specific skin problems.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Older female squirrel monkeys often experience a type of hair loss similar to chronic telogen effluvium in humans.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Hair in the front part of the scalp is more likely to fall out than hair in the back in acute telogen effluvium.

Low iron levels are strongly linked to chronic hair loss in women.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Two siblings were found to have a genetic condition causing progressive hair loss and woolly hair, which may often be misdiagnosed.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The dietary supplement helped increase hair growth in women with hair loss.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.